Two-year CAHtalyst data show crinecerfont sustains androgen reduction and lowers glucocorticoid doses in children with congenital adrenal hyperplasia. Two-year data from the phase 3 CAHtalyst ...
The FDA approved Breztri Aerosphere as the first single-inhaler triple therapy for asthma maintenance in patients 12 years and older. The US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results